I'd like to clarify the 90 day trial for Phase II participants. If I understand your guidance correctly, you would like us to identify the costs associated with a Phase II trial, but no funding is awarded until AFTER the Phase II period. This means that all of the costs to support a 3,000 end user trial are our responsibility. In the case of our solution, it is already built and in use commercially. The overwhelming majority of effort involved in deploying it for a new customer is the configuration, loading of local resources, identification of department peer support, etc. That is typically done in the first month and then we transition to sustainment. This becomes a tremendous financial risk, and one that is likely to reduce the number of proven commercial solutions you will receive. Am I understanding the structure correctly? When we are asked to identify costs for the 90 day trial period is that just so you know and can evaluate that, or is there any funding associated with supporting the 90 day field study for a Phase II trial?